Early Adoption of Dabigatran and Its Dosing in US Patients With Atrial Fibrillation: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation

BACKGROUND: Dabigatran is a novel oral anticoagulant approved for thromboprophylaxis in atrial fibrillation. Adoption patterns of this new agent in community practice are unknown. METHODS AND RESULTS: We studied patterns of dabigatran use among patients enrolled in the Outcomes Registry for Better I...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Steinberg, Benjamin A., Holmes, DaJuanicia N., Piccini, Jonathan P., Ansell, Jack, Chang, Paul, Fonarow, Gregg C., Gersh, Bernard, Mahaffey, Kenneth W., Kowey, Peter R., Ezekowitz, Michael D., Singer, Daniel E., Thomas, Laine, Peterson, Eric D., Hylek, Elaine M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Blackwell Publishing Ltd 2013
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3886732/
https://ncbi.nlm.nih.gov/pubmed/24275632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.113.000535
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi